Shandong Xinhua Pharmaceutical Co., Ltd. logo

Shandong Xinhua Pharmaceutical Co., Ltd. (XIN)

Market Closed
18 Aug, 09:48
XSTU XSTU
0. 62
-0.01
-0.8%
- Market Cap
27.89 P/E Ratio
1% Div Yield
0 Volume
0 Eps
0.62
Previous Close
Add Transaction
Day Range
0.62 0.64
Year Range
0.56 0.86
Want to track XIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

XIN closed today lower at €0.62, a decrease of -0.8% from yesterday's close, completing a monthly increase of 4.2017% or €0.02. Over the past 12 months, XIN stock lost -14.4828%.
XIN is not paying dividends to its shareholders.
The last earnings report, released on Aug 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shandong Xinhua Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 06, 2018.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

XIN Chart

Shandong Xinhua Pharmaceutical Co., Ltd. (XIN) FAQ

What is the stock price today?

The current price is €0.62.

On which exchange is it traded?

Shandong Xinhua Pharmaceutical Co., Ltd. is listed on XSTU.

What is its stock symbol?

The ticker symbol is XIN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1%.

What is its market cap?

As of today, no market cap data is available.

Has Shandong Xinhua Pharmaceutical Co., Ltd. ever had a stock split?

Shandong Xinhua Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Jul 06, 2018.

Shandong Xinhua Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Tongqing He CEO
XSTU Exchange
CNE100000411 ISIN
CN Country
7,296 Employees
27 Jun 2025 Last Dividend
6 Jul 2018 Last Split
- IPO Date

Overview

Shandong Xinhua Pharmaceutical Company Limited operates as a multifaceted pharmaceutical enterprise within the People's Republic of China and extends its reach globally, including the Americas and Europe. Established in 1943 and headquartered in Zibo, the company commits to the development, manufacturing, and marketing of a vast spectrum of pharmaceutical products. Its subsidiaries play a crucial role in this expansive operation, ensuring the company maintains its reputable position in the pharmaceutical industry. Besides its primary focus on pharmaceuticals, Shandong Xinhua Pharmaceutical Company Limited also diversifies its interests into the real estate sector, showcasing its versatile business model.

Products and Services

Shandong Xinhua Pharmaceutical Company Limited offers an extensive portfolio of products and services across various therapeutic categories:

  • Antipyretic and Analgesic Drugs: These pharmaceuticals are designed to reduce fever and relieve pain. The company's lineup of antipyretic and analgesic drugs caters to the basic healthcare needs, providing essential remedies for common conditions such as headaches, body aches, and fever.
  • Cardiovascular and Cerebrovascular Drugs: Focusing on the heart and blood vessels, this category includes medications aimed at treating conditions related to the cardiovascular and cerebrovascular systems. These drugs are crucial for the management and treatment of diseases such as hypertension, heart attacks, and strokes, thus playing a significant role in prolonging and improving the quality of life for patients with such conditions.
  • Anti-infective Drugs and Central Nervous Drugs: This category encompasses medications used to combat infections and drugs that affect the central nervous system (CNS). Anti-infective drugs include antibiotics, antivirals, antifungals, and antiparasitics, which are essential in fighting a wide range of infections. Central nervous drugs, on the other hand, target the CNS and are used in treating various conditions, including psychiatric disorders, neurodegenerative diseases, and pain management.
  • Other Drugs: Shandong Xinhua Pharmaceutical extends its product range to include other pharmaceuticals that cater to a variety of medical conditions, emphasizing the company's commitment to addressing a broad spectrum of healthcare needs.

In addition to its pharmaceutical products, Shandong Xinhua Pharmaceutical Company Limited engages in the real estate sector, showcasing its versatility by venturing into development projects. This diversification strategy highlights the company's dynamic approach to business, aiming to capture growth opportunities beyond its core pharmaceutical endeavors.

Contact Information

Address: No. 1 Lutai Avenue, Zibo, China, 255086
Phone: 86 53 3219 5636